(RTTNews) – GeneDx (WGS) announced Thursday the appointment of Bryan Dechair as Chief Operating Officer, effective immediately.
In the newly formed purpose, Bryan will document Katherine Stueland, the CEO and president, and would probably do well to calmly wait for the company’s leadership.
As Chief Operating Officer, Bryan will oversee GeneDx’s product and knowledge, operations, medical affairs, innovation and program management groups.
“Bryan’s intense medical, technical and operational skills and proven means of leading scalable transformations will be central to realizing our strategic vision and leading the adoption of genomic insights in healthcare,” Stueland acknowledged.
The views and opinions expressed herein are those of the creator and do not necessarily reflect those of Nasdaq, Inc.
Leave a Reply